Member Info for Bermondsey

Current market cap a fair reflection of where the company is. Its essentially a retail company with focus on wellness. Share price wont budge if and until those pie in the sky figures come to fruition. All this guff about it being undervalued just look at latest finacials they tell all. I want callum to succeed but saying it should be higher just because you bought some shares wont cut it

Looks like they have corrected the original disclosure this afternoon - shows the 9.5% they held before increase

Have picked up 10% or am I missing the big picture here. Surprised no movement in sp so assume funds swapping shares between themselves or something

Invariably equity raises are at a discount or you would just buy the shares on open market. Any raise will sub 1.2. Its a huge risk.

That some AI powered development could make our product obsolete before it hits market?

Https://www.retailgazette.co.uk/blog/2025/09/high-street-bounces-back/

Printed 3 x

Some colour on evolution of launch strategy:

following the progress made by iGenomeDX....strategy has developed to more appropriately reflect the large market opportunity....enabling a much wider co-ordinated and comprehensive campaign to roll out the CIZ1B biomarker test in North America

Although still no line on the sand for actual launch date.

No fears as to funding of advance royalty payments

Exciting rns but not convinced it has told us anything we hadn't already deduced.

Truth is mate nobody knows. This is pharma so patience is key. Look at the board composition, a group of doctors pursuing the goal of early cancer detection. Some pessimism coming into the board recently because the company doesnt focus on spiking / massaging the share price. Thats a plus, they're focused on the business of delivering product. Its not a life style company - salaries are pretty low, directors/founders/ employees rewarded heavily in shares. Its frustrating we don't know when our first product will be launched, I do feel its close - particularly since Dawn devoting more time to the company. Ciz inc projected sales haven't set the world alight but nobody really has a clue how well this product will do. Dont listen to the rampers nor the derampers. Sum up your own financial position and take whatever action you see is best for you.

I sent an email to fca on Friday. Perhaps will flush out a tr1 or two

Hi 5 8

Where do I find trades on yahoo finance?

That's 24% of share capital - takeover? Sure tr1s to be issued ?

LB I also registered back when looking for the prospectus. Interestingly ciz team will be present to discuss our test but provisers of gastric test not mentioned. I'll be listening in for any case on launch date. I make it 2130 bst.

Assume this is aimed at my question Greend, thanks

Shin ciz have a 10% equity stake in ciz bio (pre dilution) - so no not our test but we do have a financial interest

We have 10% interest in cizbio before this equity raise completes. Anyone worked out what diluted interest is?

Makes you question which product they will concentrate marketing spend (ref figures in cizbio prospectus)

I take some comfort frazer lang added a few more quid only a couple of months ago. He knows more than us and happy to continually up his stake. The amount raised must anticipate arrival of 250k commission end of July or would have been higher. If it hasn't been paid then the market would need to be informed by rns. I wouldn't be surprised if another cash call comes round irrespective of the advance royalties, there is limited income and now exploring non - US markets would expect to incur legal and professional fees as well as usual operating costs. I've held these for too long to bail as it starts to get interesting. Echo the thoughts of reducing risk on the spike a few years ago, could have taken my stake off the table and still hold a decent amount. Lesson learnt the hard way again.

Good to see buy backs resume at low price

Im pretty sure youre bang on the money Cromer, restoration of shares to market delayed due to the company rather than regulator. Having said that I can't find a definitive answer, fca rules simply say when the fca are satisfied the shares will be restored. The reason given for voluntary suspension was the company cannot "currently provide the market with an accurate update of its financial and trading position". Given financial statements now issued i would think it would not take fca long to consider and approve application to restore. Have seen it same day on other shares. The pessimist in me thinks callum is equity raising behind scenes and the two are linked. Perhaps protecting

from a dirt cheap raise or perhaps engineering a dirt cheap raise. That's my gut feeling based on nothing the company has said.